Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines

Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( ) and silybin B ( ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few st...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 27; no. 5; p. 1702
Main Authors Romanucci, Valeria, Pagano, Rita, Lembo, Antonio, Capasso, Domenica, Di Gaetano, Sonia, Zarrelli, Armando, Di Fabio, Giovanni
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 05.03.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( ) and silybin B ( ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form ( , and ) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO ) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers ( and ) and dimers ( , and ) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the and go completely into apoptosis, whereas only part of the cells treated with and were found to be in apoptosis.
AbstractList Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( 1a ) and silybin B ( 1b ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form ( 6aa , 6ab and 6bb ) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO ● ) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers ( 1a and 1b ) and dimers ( 6aa , 6ab and 6bb ) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the 1a and 1b go completely into apoptosis, whereas only part of the cells treated with 6aa and 6ab were found to be in apoptosis.
Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A ( ) and silybin B ( ), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form ( , and ) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO ) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers ( and ) and dimers ( , and ) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the and go completely into apoptosis, whereas only part of the cells treated with and were found to be in apoptosis.
Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin A (1a) and silybin B (1b), which we call here silybins. Despite the high interest in the activity of this flavonolignan, there are still few studies that give due attention to the role of its stereochemistry and, there is still today a strong need to investigate in this area. In this regard, here we report a study concerning the radical scavenger ability and the antiproliferative activity on different cell lines, both of silybins and phosphodiester-linked silybin dimers. An efficient synthetic strategy to obtain silybin dimers in an optical pure form (6aa, 6ab and 6bb) starting from a suitable building block of silybin A and silybin B, obtained by us from natural extract silibinin, was proposed. New dimers show strong antioxidant properties, determined through hydroxyl radical (HO●) scavenging ability, comparable to the value reported for known potent antioxidants such as quercetin. A preliminary screening was performed by treating cells with 10 and 50 μM concentrations for 48 h to identify the most sensitive cell lines. The results show that silibinin compounds were active on Jurkat, A375, WM266, and HeLa, but at the tested concentrations, they did not interfere with the growth of PANC, MCF-7, HDF or U87. In particular, both monomers (1a and 1b) and dimers (6aa, 6ab and 6bb) present selective anti-proliferative activity towards leukemia cells in the mid-micromolar range and are poorly active on normal cells. They exhibit different mechanisms of action in fact all the cells treated with the 1a and 1b go completely into apoptosis, whereas only part of the cells treated with 6aa and 6ab were found to be in apoptosis.
Author Di Fabio, Giovanni
Capasso, Domenica
Di Gaetano, Sonia
Romanucci, Valeria
Pagano, Rita
Lembo, Antonio
Zarrelli, Armando
AuthorAffiliation 4 Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy
3 Center for Life Sciences and Technologies (CESTEV), University of Naples “Federico II“, Via De Amicis 95, 80145 Napoli, Italy
1 Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy; valeria.romanucci@unina.it (V.R.); rita.pagano@unina.it (R.P.); antonio.lembo@unina.it (A.L.); zarrelli@unina.it (A.Z.)
5 AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull’Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy
2 Interuniversity Research Centre on Bioactive Peptides (CIRPeB), University of Naples “Federico II“, Via Mezzocannone 16, 80134 Napoli, Italy; domenica.capasso@unina.it (D.C.); digaetan@unina.it (S.D.G.)
AuthorAffiliation_xml – name: 5 AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull’Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy
– name: 4 Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy
– name: 3 Center for Life Sciences and Technologies (CESTEV), University of Naples “Federico II“, Via De Amicis 95, 80145 Napoli, Italy
– name: 2 Interuniversity Research Centre on Bioactive Peptides (CIRPeB), University of Naples “Federico II“, Via Mezzocannone 16, 80134 Napoli, Italy; domenica.capasso@unina.it (D.C.); digaetan@unina.it (S.D.G.)
– name: 1 Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy; valeria.romanucci@unina.it (V.R.); rita.pagano@unina.it (R.P.); antonio.lembo@unina.it (A.L.); zarrelli@unina.it (A.Z.)
Author_xml – sequence: 1
  givenname: Valeria
  orcidid: 0000-0003-0317-5140
  surname: Romanucci
  fullname: Romanucci, Valeria
  organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy
– sequence: 2
  givenname: Rita
  orcidid: 0000-0002-9402-389X
  surname: Pagano
  fullname: Pagano, Rita
  organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy
– sequence: 3
  givenname: Antonio
  surname: Lembo
  fullname: Lembo, Antonio
  organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy
– sequence: 4
  givenname: Domenica
  orcidid: 0000-0001-7201-3431
  surname: Capasso
  fullname: Capasso, Domenica
  organization: Center for Life Sciences and Technologies (CESTEV), University of Naples "Federico II", Via De Amicis 95, 80145 Napoli, Italy
– sequence: 5
  givenname: Sonia
  orcidid: 0000-0001-5523-3619
  surname: Di Gaetano
  fullname: Di Gaetano, Sonia
  organization: Institute of Biostructures and Bioimaging-CNR, Via Mezzocannone 16, 80134 Napoli, Italy
– sequence: 6
  givenname: Armando
  orcidid: 0000-0001-7866-821X
  surname: Zarrelli
  fullname: Zarrelli, Armando
  organization: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Napoli, Italy
– sequence: 7
  givenname: Giovanni
  orcidid: 0000-0003-2912-4827
  surname: Di Fabio
  fullname: Di Fabio, Giovanni
  organization: AIPRAS Onlus (Associazione Italiana per la Promozione delle Ricerche sull'Ambiente e la Salute umana Onlus), Via Campellone 50, 82030 Dugenta, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35268803$$D View this record in MEDLINE/PubMed
BookMark eNplkk1vEzEQhleoiH7AD-CCLHHpJcUf6_UuB6QofFWKREXhbNneceLIawd7Nyj_Hoe0VQunsWbeeTTzes6rkxADVNVrgq8Y6_C7IXowk4dMBeZEYPqsOiM1xTOG6-7k0fu0Os95gzElNeEvqlPGadO2mJ1Vu5t1zNt17B3kERK6dX6vXUAf3QApo5v4G5KdPPquemeUR7dG7SCsSu09mqN5GN02Re8sJDW6HaC5KcGNexQPDFvyEEa0UMEU-AK8R0sXIL-snlvlM7y6ixfVz8-ffiy-zpbfvlwv5suZqWs-zoympNcECG7K6L0FxqGzWlusG1O3Qhjeaa6UrjVT2nYGWkxrIxhXteK2YxfV9ZHbR7WR2-QGlfYyKif_JmJaSZVGZzxIzayw0DGhRUFj1fXYKtGIhraNbWldWB-OrO2kB-hNWSwp_wT6tBLcWq7iTrYdIULwAri8A6T4ayp-y8FlUzxRAeKUJW1YKygv_1Wkb_-RbuKUQrHqoCqwtqOsqMhRZVLMOYF9GIZgebgQ-d-FlJ43j7d46Lg_CfYHOaq9sw
Cites_doi 10.1039/D1QO00045D
10.1016/j.ejmech.2016.07.070
10.3390/antiox8070236
10.1021/bi101731d
10.1055/s-0032-1328703
10.1016/S0031-9422(00)83860-1
10.1002/anie.201000044
10.1016/j.ejmech.2019.06.010
10.1016/j.bioorg.2018.01.026
10.2174/092986707779941159
10.1021/acschemneuro.0c00232
10.1002/hlca.201400282
10.1021/acs.jmedchem.8b00834
10.3390/molecules22081323
10.1039/C7MB00190H
10.1016/j.tetlet.2013.09.035
10.1055/s-0032-1317688
10.1371/journal.pone.0106441
10.3390/ijms22157885
10.1021/jp075814h
10.1016/j.abb.2019.05.009
10.1039/C3NP70122K
10.1016/j.bmcl.2011.06.049
10.1021/np030414g
10.1016/j.freeradbiomed.2008.11.016
10.1021/acschemneuro.7b00110
10.2174/092986706775197908
10.3390/ijms12084861
10.1021/jm400970m
10.3390/molecules24010108
10.1021/acs.jmedchem.9b00262
10.1016/j.bmcl.2014.10.023
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/molecules27051702
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health Medical collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Access via ProQuest (Open Access)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health Medical collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_b3f7fe937b7c480a9d0fa7676286f824
10_3390_molecules27051702
35268803
Genre Journal Article
GroupedDBID ---
0R~
123
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
ABDBF
ABJCF
ABUWG
ACGFO
ACIWK
ACPRK
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1I
DIK
DU5
E3Z
EBD
ECM
EIF
EMOBN
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
HZ~
I09
IAO
ITC
KB.
KQ8
LK8
M1P
M7P
MODMG
M~E
NPM
O-U
O9-
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
SV3
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c445t-cb21db1e106214dfe35e9fbbf0b6c4877c59b5aab4b3abf9ce8024c735a4a5f93
IEDL.DBID RPM
ISSN 1420-3049
IngestDate Tue Oct 22 14:42:50 EDT 2024
Tue Sep 17 21:21:52 EDT 2024
Sat Oct 26 00:18:30 EDT 2024
Sat Nov 09 09:41:48 EST 2024
Thu Sep 26 21:06:40 EDT 2024
Sat Sep 28 08:20:23 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords radical scavenger of ROS
apoptosis
silibinin
leukemia cells
flavonolignan dimers
silybin
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c445t-cb21db1e106214dfe35e9fbbf0b6c4877c59b5aab4b3abf9ce8024c735a4a5f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7866-821X
0000-0001-5523-3619
0000-0003-2912-4827
0000-0003-0317-5140
0000-0001-7201-3431
0000-0002-9402-389X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911775/
PMID 35268803
PQID 2637758923
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_b3f7fe937b7c480a9d0fa7676286f824
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8911775
proquest_miscellaneous_2638725049
proquest_journals_2637758923
crossref_primary_10_3390_molecules27051702
pubmed_primary_35268803
PublicationCentury 2000
PublicationDate 20220305
PublicationDateYYYYMMDD 2022-03-05
PublicationDate_xml – month: 3
  year: 2022
  text: 20220305
  day: 5
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Wong (ref_6) 2018; 61
Zarrelli (ref_19) 2011; 21
ref_13
Romanucci (ref_21) 2013; 79
Cillard (ref_24) 1987; 26
ref_30
Lee (ref_9) 2003; 66
Trouillas (ref_25) 2008; 112
Ge (ref_28) 2011; 12
Berube (ref_4) 2006; 13
Si (ref_29) 2019; 671
ref_17
Iadonisi (ref_31) 2021; 8
Thapa (ref_5) 2011; 50
Quideau (ref_3) 2011; 50
Zarrelli (ref_15) 2014; 24
Romanucci (ref_14) 2018; 77
Biedermann (ref_10) 2014; 31
Zarrelli (ref_20) 2012; 24
Romanucci (ref_16) 2013; 54
Gazak (ref_11) 2007; 14
Guo (ref_27) 2021; 12
Capasso (ref_33) 2017; 13
Polachi (ref_12) 2016; 123
Ahmed (ref_22) 2020; 11
Pelliccia (ref_32) 2020; 63
Zarrelli (ref_18) 2015; 98
Neha (ref_1) 2019; 178
Rosini (ref_2) 2014; 57
ref_8
Sciacca (ref_23) 2017; 8
ref_7
Sedmera (ref_26) 2009; 46
References_xml – volume: 8
  start-page: 1823
  year: 2021
  ident: ref_31
  article-title: Switchable synthesis of glycosyl selenides or diselenides with direct use of selenium as the selenating agent
  publication-title: Org. Chem. Front.
  doi: 10.1039/D1QO00045D
  contributor:
    fullname: Iadonisi
– volume: 123
  start-page: 577
  year: 2016
  ident: ref_12
  article-title: Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer—A comprehensive review
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2016.07.070
  contributor:
    fullname: Polachi
– ident: ref_17
  doi: 10.3390/antiox8070236
– volume: 50
  start-page: 2445
  year: 2011
  ident: ref_5
  article-title: Biflavonoids Are Superior to Monoflavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis via Accumulation of Nontoxic Oligomer-like Structures
  publication-title: Biochemistry
  doi: 10.1021/bi101731d
  contributor:
    fullname: Thapa
– volume: 12
  start-page: 736
  year: 2021
  ident: ref_27
  article-title: Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma
  publication-title: Front. Pharmacol.
  contributor:
    fullname: Guo
– volume: 79
  start-page: 1077
  year: 2013
  ident: ref_21
  article-title: A Rapid and Simple Chromatographic Separation of Diastereomers of Silibinin and Their Oxidation to Produce 2,3-Dehydrosilybin Enantiomers in an Optically Pure Form
  publication-title: Planta Med.
  doi: 10.1055/s-0032-1328703
  contributor:
    fullname: Romanucci
– volume: 26
  start-page: 2489
  year: 1987
  ident: ref_24
  article-title: Hydroxyl radical scavenging activity of flavonoids
  publication-title: Phytochemistry
  doi: 10.1016/S0031-9422(00)83860-1
  contributor:
    fullname: Cillard
– volume: 50
  start-page: 586
  year: 2011
  ident: ref_3
  article-title: Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
  publication-title: Angew. Chemie Int. Ed.
  doi: 10.1002/anie.201000044
  contributor:
    fullname: Quideau
– volume: 178
  start-page: 687
  year: 2019
  ident: ref_1
  article-title: Medicinal prospects of antioxidants: A review
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2019.06.010
  contributor:
    fullname: Neha
– volume: 77
  start-page: 349
  year: 2018
  ident: ref_14
  article-title: Silibinin phosphodiester glyco-conjugates: Synthesis, redox behaviour and biological investigations
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2018.01.026
  contributor:
    fullname: Romanucci
– volume: 14
  start-page: 315
  year: 2007
  ident: ref_11
  article-title: Silybin and Silymarin—New and Emerging Applications in Medicine
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986707779941159
  contributor:
    fullname: Gazak
– volume: 11
  start-page: 2566
  year: 2020
  ident: ref_22
  article-title: Trehalose Conjugates of silybin as prodrugs for targeting toxic Aβ aggregates
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.0c00232
  contributor:
    fullname: Ahmed
– volume: 98
  start-page: 399
  year: 2015
  ident: ref_18
  article-title: Synthesis of New Silybin Derivatives and Evaluation of Their Antioxidant Properties
  publication-title: Helv. Chim. Acta
  doi: 10.1002/hlca.201400282
  contributor:
    fullname: Zarrelli
– volume: 61
  start-page: 9931
  year: 2018
  ident: ref_6
  article-title: Discovery of Novel Flavonoid Dimers to Reverse Multidrug Resistance Protein 1 (MRP1, ABCC1) Mediated Drug Resistance in Cancers Using a High Throughput Platform with “Click Chemistry”
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.8b00834
  contributor:
    fullname: Wong
– ident: ref_8
  doi: 10.3390/molecules22081323
– volume: 13
  start-page: 1619
  year: 2017
  ident: ref_33
  article-title: Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein
  publication-title: Mol. Biosyst.
  doi: 10.1039/C7MB00190H
  contributor:
    fullname: Capasso
– volume: 54
  start-page: 6279
  year: 2013
  ident: ref_16
  article-title: Microwave-assisted oxidation of silibinin: A simple and preparative method for the synthesis of improved radical scavengers
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2013.09.035
  contributor:
    fullname: Romanucci
– volume: 24
  start-page: 45
  year: 2012
  ident: ref_20
  article-title: New Silybin Scaffold for Chemical Diversification: Synthesis of Novel 23-Phosphodiester Silybin Conjugates
  publication-title: Synlett
  doi: 10.1055/s-0032-1317688
  contributor:
    fullname: Zarrelli
– ident: ref_30
  doi: 10.1371/journal.pone.0106441
– ident: ref_13
  doi: 10.3390/ijms22157885
– volume: 112
  start-page: 1054
  year: 2008
  ident: ref_25
  article-title: Mechanism of the Antioxidant Action of Silybin and 2,3-Dehydrosilybin Flavonolignans: A Joint Experimental and Theoretical Study
  publication-title: J. Phys. Chem. A
  doi: 10.1021/jp075814h
  contributor:
    fullname: Trouillas
– volume: 671
  start-page: 42
  year: 2019
  ident: ref_29
  article-title: Silibinin-induced apoptosis of breast cancer cells involves mitochondrial impairment
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2019.05.009
  contributor:
    fullname: Si
– volume: 31
  start-page: 1138
  year: 2014
  ident: ref_10
  article-title: Chemistry of silybin
  publication-title: Nat. Prod. Rep.
  doi: 10.1039/C3NP70122K
  contributor:
    fullname: Biedermann
– volume: 21
  start-page: 4389
  year: 2011
  ident: ref_19
  article-title: New C-23 modified of silybin and 2,3-dehydrosilybin: Synthesis and preliminary evaluation of antioxidant properties
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2011.06.049
  contributor:
    fullname: Zarrelli
– volume: 66
  start-page: 1632
  year: 2003
  ident: ref_9
  article-title: Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum marianum (Milk Thistle)
  publication-title: J. Nat. Prod.
  doi: 10.1021/np030414g
  contributor:
    fullname: Lee
– volume: 46
  start-page: 745
  year: 2009
  ident: ref_26
  article-title: Molecular mechanisms of silybin and 2,3-dehydrosilybin antiradical activity—Role of individual hydroxyl groups
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2008.11.016
  contributor:
    fullname: Sedmera
– volume: 8
  start-page: 1767
  year: 2017
  ident: ref_23
  article-title: Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.7b00110
  contributor:
    fullname: Sciacca
– volume: 13
  start-page: 131
  year: 2006
  ident: ref_4
  article-title: Natural and Synthetic Biologically Active Dimeric Molecules: Anticancer Agents, Anti-HIV Agents, Steroid Derivatives and Opioid Antagonists
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986706775197908
  contributor:
    fullname: Berube
– volume: 12
  start-page: 4861
  year: 2011
  ident: ref_28
  article-title: Silibinin Causes Apoptosis and Cell Cycle Arrest in Some Human Pancreatic Cancer Cells
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms12084861
  contributor:
    fullname: Ge
– volume: 57
  start-page: 2821
  year: 2014
  ident: ref_2
  article-title: Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
  publication-title: J. Med. Chem.
  doi: 10.1021/jm400970m
  contributor:
    fullname: Rosini
– ident: ref_7
  doi: 10.3390/molecules24010108
– volume: 63
  start-page: 2035
  year: 2020
  ident: ref_32
  article-title: Bio-Inspired Dual-Selective BCL-2/c-MYC G-Quadruplex Binders: Design, Synthesis, and Anticancer Activity of Drug-like Imidazo[2,1- i]purine Derivatives
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b00262
  contributor:
    fullname: Pelliccia
– volume: 24
  start-page: 5147
  year: 2014
  ident: ref_15
  article-title: New silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2014.10.023
  contributor:
    fullname: Zarrelli
SSID ssj0021415
Score 2.3951893
Snippet Silibinin is the main biologically active component of silymarin extract and consists of a mixture 1:1 of two diastereoisomeric flavonolignans, namely silybin...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1702
SubjectTerms Alzheimer's disease
Angiogenesis
Antioxidants
Antioxidants - chemistry
Antioxidants - pharmacology
Antiproliferatives
Apoptosis
Biological activity
Cancer
Cell cycle
Cell Line
Fibroblasts
Flavonoids
flavonolignan dimers
Hydroxyl radicals
Leukemia
leukemia cells
Metastasis
Neoplasms
Oxidative stress
Quercetin
radical scavenger of ROS
Scavenging
Silibinin
silybin
Silybin - pharmacology
Silymarin
Silymarin - chemistry
Silymarin - pharmacology
Stereochemistry
Tumor cell lines
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1RT9swELYmXtgLYmOMbAwZaU-TIlI7jmPeSgEhtE0IhsRbZDs2rVSSiqaT-PfcxUlFAYkXXuMkcu4uvjvf-fsI-ZmVGWPODWKv87SlMIs1S01sJbOQfSQ2b-l8_vzNzq7T8xtx84TqC3vCAjxwENyB4V56B07USJvmiVZl4rXMJB6p9DkLSKCJ6pOpLtUagF8KNUwOSf3BXaCadXMmEZOq20PpvVAL1v9ahPm8UfKJ5zndJBtdyEiHYaqfyAdXfSbro56pbYv8vxjX89m4xoZAEBO9mkwfIOGlxxPclKYXSITmF1N6qduiDL2yyCF_C2OHdEiHVTOZIXePdwEFnA5toJSgNb4jEKg0dIT2cU9Hbjqlv7FZ_gu5Pj35NzqLOz6FGMQumtgaNijNwEEWCAIqvePCKW-MT0wGspXSCmWE1iY1XBuvrMvBg1vJhU618Ipvk7WqrtwOoaXhpYdQDWTJYak1Ki1dnjmupcosM2lEfvXyLWYBNqOAdAOVUbxQRkSOUAPLGxHxur0AdlB0dlC8ZQcR2e31V3S_4bxgGZeQEEEQG5H95TBoB6siunL1or0nlwjkpiLyNah7ORMkD4AFDp6WK4awMtXVkWoybkG6c4XlcPHtPb7tO_nI8NQFtr6JXbLW3C_cD4iFGrPXmv0jhawLzA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELcGe4CXaR_AytjkSXtCimjsOI73MnXdOjQBQnxIvEW2Y9NKXdK1KdL--905SaEM7TV2EuvufL4v34-QT2mRMuZcHHmdJQHCLNIsMZGVzIL30bdZgPM5PUuPr5OfN-KmDbgt2rLKTicGRV1UFmPkRyzlEmxbsEe-zH5HiBqF2dUWQmODPI-ZlOh8ZaMfK4crhtOpyWRycO2PfjWAs27BJHamaiMp3VkUWvY_ZWc-Lpd8cP6MXpIXreFIBw2nX5FnrnxNtoYdXtsbcnc-rhazcYVlgUAsejmZ_gG3l36bYGianiMcml9O6YUOqRl6aRFJ_hbGPtMBHZT1ZIYIPt41vcDpwDbAErTCbzQwKjUdopTM6dBNp_QES-Z3yPXo-9XwOGpRFSIgvqgja1hcmNiBLwgEKrzjwilvjO-b1IL7Iq1QRmhtEsO18cq6DM5xK7nQiRZe8V2yWVale0toYXjhwWADWnJQuEYlhctSx7VUqWUm6ZHDjr75rGmekYPTgczI_2FGj3xFDqwmYt_r8KCa3-btNsoN99I7MKmMhLX2tSr6XstU4gVbnzH440HHv7zdjIv8XnR65ONqGLiDuRFdumoZ5mQS27mpHtlr2L1aCUIIgJqDt-WaIKwtdX2knIxDq-5MYVJc7P9_We_INsNbFVjaJg7IZj1fuvdg69TmQxDovw85A3c
  priority: 102
  providerName: ProQuest
Title Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines
URI https://www.ncbi.nlm.nih.gov/pubmed/35268803
https://www.proquest.com/docview/2637758923
https://search.proquest.com/docview/2638725049
https://pubmed.ncbi.nlm.nih.gov/PMC8911775
https://doaj.org/article/b3f7fe937b7c480a9d0fa7676286f824
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa28QAviN8ERmUknpCypnYSJ7x1YWVCbKo2JvUtsh17jZQmVZsi8d9z5yQVBZ54yUPsJKe7z_Gdfb6PkA9xETNmzMS3MgkdhZkvWah8LZiG6CPQiaPzubqOL-_Cr4tocUSi4SyMS9rXqjyrq9VZXS5dbuV6pcdDnth4fpUlKW41RuNjcgwAHUL0PsqawJTUbV9yiOfHq45l1myZwHJUAdLXYE14wC0_mItcyf5_-Zl_pkv-Nv_MnpDHveNIp52AT8mRqZ-Rh9nA1_ac_Jgvm-162WBaICiL3pbVTwh76ecSl6bpHOnQ7K6iN9JtzdBbjUzy99D2iU7ptG7LNTL4WNPVAqdT3RFL0Abf0dGotDRDlGxoZqqKfsOU-RfkbnbxPbv0e1YFH5Qftb5WbFKoiYFYEHRVWMMjk1qlbKBiDeGL0FGqIilVqLhUNtUmgXlcCx7JUEY25S_JSd3U5jWhheKFBYcN1Mrhh6vSsDBJbLgUaayZCj3ycdBvvu6KZ-QQdKBd8r_s4pFztMC-I9a9djeazX3eWz9X3AprwKVSAmQNZFoEVopY4AFbmzD44ulgv7wfjNucxRzQkoAr65H3-2awDu6NyNo0O9cnEVjOLfXIq87ce0kGuHhEHADhQNTDFkCuK9XdI_XNfz_5ljxieOACs96iU3LSbnbmHbhBrRoB-BcCrsnsy4g8OL-4nt-M3JLCyA2IXw3WEL4
link.rule.ids 230,315,730,783,787,867,888,2109,12068,12777,21400,27936,27937,31731,31732,33385,33386,33756,33757,43322,43612,43817,53804,53806,74073,74363,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgexgvCDY-ysbwJJ6QorV2HMe8oFI2FdZNE9ukvkW2Y6-VStK1KRL_PXdO0q2AeI2dxLo7n-_L9yPkfZInjDnXi7xO4wBhFmkWm8hKZsH76No0wPmcXyTDm_jbWIybgNuyKatsdWJQ1HlpMUZ-zBIuwbYFe-TT_C5C1CjMrjYQGo_JNvbhQgQDOb53uHpwOtWZTA6u_fGPGnDWLZnEzlRNJKU9i0LL_n_ZmX-WSz44f06fkaeN4Uj7Naefk0eu2CU7gxavbY_8vJyUy_mkxLJAIBa9ms5-gdtLv0wxNE0vEQ7Nr2b0uw6pGXplEUn-FsY-0j7tF9V0jgg-3tW9wGnf1sAStMRv1DAqFR2glCzowM1mdIQl8y_IzenJ9WAYNagKERBfVJE1rJebngNfEAiUe8eFU94Y3zWJBfdFWqGM0NrEhmvjlXUpnONWcqFjLbziL8lWURbuNaG54bkHgw1oyUHhGhXnLk0c11Illpm4Qz609M3mdfOMDJwOZEb2FzM65DNyYD0R-16HB-XiNmu2UWa4l96BSWUkrLWrVd71WiYSL9j6lMEfD1r-Zc1mXGb3otMhR-th4A7mRnThylWYk0ps56Y65FXN7vVKEEIA1By8LTcEYWOpmyPFdBJadacKk-Lizf-X9Y7sDK_PR9no68XZPnnC8IYFlrmJA7JVLVbuLdg9lTkMwv0bQOQGWQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSMDLxOfoGGAknpCitnYcx7yg0lENGFPFmNS3yHbstVJJSpsh8d9z5zgdBcRrnA_n7nwfvvP9CHmVlRljzg0Tr_M0QJglmqUmsZJZiD4GNg9wPp_PspOL9ONMzGL90yaWVXY6MSjqsra4R95nGZfg24I_0vexLGJ6PHm7-p4gghRmWiOcxk1yS0KUgjIvZ9fB1xAsVZvV5BDm97-14LNuwyR2qYq7Kp1dCu37_-Vz_lk6-Zstmtwj-9GJpKOW6_fJDVc9IHfGHXbbQ_JjOq83q3mNJYJAOHq-WP6EEJgeL3Cbmk4RGg3-j37RIU1Dzy2iyl_C2Bs6oqOqWawQzce7ti84HdkWZILW-I4WUqWhY5SYNR275ZKeYvn8I3Ixef91fJJEhIUEGCGaxBo2LM3QQVwIBCq948Ipb4wfmMxCKCOtUEZobVLDtfHKuhxsupVc6FQLr_hjslfVlXtCaGl46cF5A1pyUL5GpaXLM8e1VJllJu2R1x19i1XbSKOAAASZUfzFjB55hxzY3og9sMOFen1ZxCVVGO6ld-BeGQlzHWhVDryWmcTDtj5n8MWjjn9FXJib4lqMeuTldhi4g3kSXbn6KtyTS2ztpnrkoGX3diYIJwAqD56WO4KwM9XdkWoxD227c4UJcnH4_2m9ILdBrovTD2efnpK7DA9bYMWbOCJ7zfrKPQMXqDHPg2z_AkhRCpE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phosphodiester+Silybin+Dimers+Powerful+Radical+Scavengers%3A+A+Antiproliferative+Activity+on+Different+Cancer+Cell+Lines&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Romanucci%2C+Valeria&rft.au=Pagano%2C+Rita&rft.au=Lembo%2C+Antonio&rft.au=Capasso%2C+Domenica&rft.date=2022-03-05&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=27&rft.issue=5&rft.spage=1702&rft_id=info:doi/10.3390%2Fmolecules27051702&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon